An engineered biosynthetic–synthetic platform for production of halogenated indolmycin antibiotics
A semi-synthetic system for producing indolmycin, an antibiotic, was developed and used to make indole-substituted, halogenated derivatives of indolmycin, some with modest bioactivity against methicillin-resistant Staphylococcus aureus.
2020 ◽
Vol 205
◽
pp. 112533
◽
2002 ◽
Vol 12
(21)
◽
pp. 3027-3031
◽
1993 ◽
Vol 46
(3)
◽
pp. 531-534
◽
2016 ◽
Vol 25
(11)
◽
pp. 2691-2697
◽
2003 ◽
Vol 47
(6)
◽
pp. 2043-2046
◽
Keyword(s):